|
|
| | 5H-Thiazolo[3,2-a]pyridin-5-one, 7-[(1S)-1-[4-amino-3-[3-fluoro-4-(1-methylethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-(3-fluorophenyl)-3-methyl- Basic information |
| | 5H-Thiazolo[3,2-a]pyridin-5-one, 7-[(1S)-1-[4-amino-3-[3-fluoro-4-(1-methylethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-(3-fluorophenyl)-3-methyl- Chemical Properties |
| Boiling point | 804.5±65.0 °C(Predicted) | | density | 1.44±0.1 g/cm3(Predicted) | | pka | 3.49±0.30(Predicted) |
| | 5H-Thiazolo[3,2-a]pyridin-5-one, 7-[(1S)-1-[4-amino-3-[3-fluoro-4-(1-methylethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-(3-fluorophenyl)-3-methyl- Usage And Synthesis |
| Uses | PI3K-IN-27 is a potent inhibitor of PI3K. PI3K belongs to a large family of lipid signaling kinase that plays key role in cellular process including cell growth, differentiation, migration and apoptosis. PI3K-IN-27 has the potential for the research of hyper-proliferative diseases like cancer and inflammation, or immune and autoimmune diseases (extracted from patent WO2021233227A1, compound 1)[1]. | | References | [1] Zuwen ZHOU, et al. Compounds as protein kinase inhibitors. Patent WO2021233227A1. |
| | 5H-Thiazolo[3,2-a]pyridin-5-one, 7-[(1S)-1-[4-amino-3-[3-fluoro-4-(1-methylethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-(3-fluorophenyl)-3-methyl- Preparation Products And Raw materials |
|